Janice May Wilson, MD - Medicare Dermatology in Galveston, TX

Janice May Wilson, MD is a medicare enrolled "Dermatology" physician in Galveston, Texas. She graduated from medical school in 2012 and has 12 years of diverse experience with area of expertise as Dermatology. She is a member of the group practice University Of Texas Medical Branch Faculty Group Practice and her current practice location is 301 University Blvd, University Of Texas Medical Branch-dermatology, Galveston, Texas. You can reach out to her office (for appointments etc.) via phone at (409) 772-1911.

Janice May Wilson is licensed to practice in Texas (license number BP20046284) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1457612749.

Contact Information

Janice May Wilson, MD
301 University Blvd, University Of Texas Medical Branch-dermatology,
Galveston, TX 77555-0783
(409) 772-1911
(409) 772-4456



Physician's Profile

Full NameJanice May Wilson
GenderFemale
SpecialityDermatology
Experience12 Years
Location301 University Blvd, Galveston, Texas
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Janice May Wilson graduated from medical school in 2012
  NPI Data:
  • NPI Number: 1457612749
  • Provider Enumeration Date: 06/03/2012
  • Last Update Date: 02/08/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 9133410806
  • Enrollment ID: I20160628000770

Medical Identifiers

Medical identifiers for Janice May Wilson such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1457612749NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207ND0900XDermatology - Dermatopathology Q5126 (Texas)Secondary
207R00000XInternal Medicine BP10044148 (Texas)Secondary
207N00000XDermatology BP20046284 (Texas)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
University Of Texas Medical Branch GalvestonGalveston, TXHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
University Of Texas Medical Branch Faculty Group Practice3375456734875

News Archive

LifeVest wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest

The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.

Researchers develop brown fat detection method to combat obesity

When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at The University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.

Diflunisal drug reduces neurological decline in patients with familial transthyretin amyloidosis

A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.

Feeling depressed and fatigued does not increase a person's risk for cancer

...according to a new study. Severely exhausted people, however, do engage in behavior that is associated with a higher cancer risk.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Janice May Wilson allows following entities to bill medicare on her behalf.
Entity NameUtmb Faculty Group Practice
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1942241146
PECOS PAC ID: 3375456734
Enrollment ID: O20031112000438

News Archive

LifeVest wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest

The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.

Researchers develop brown fat detection method to combat obesity

When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at The University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.

Diflunisal drug reduces neurological decline in patients with familial transthyretin amyloidosis

A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.

Feeling depressed and fatigued does not increase a person's risk for cancer

...according to a new study. Severely exhausted people, however, do engage in behavior that is associated with a higher cancer risk.

Read more Medical News

› Verified 2 days ago

Entity NameMotaz Albahra Md Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1306879705
PECOS PAC ID: 3678576006
Enrollment ID: O20060824000276

News Archive

LifeVest wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest

The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.

Researchers develop brown fat detection method to combat obesity

When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at The University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.

Diflunisal drug reduces neurological decline in patients with familial transthyretin amyloidosis

A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.

Feeling depressed and fatigued does not increase a person's risk for cancer

...according to a new study. Severely exhausted people, however, do engage in behavior that is associated with a higher cancer risk.

Read more Medical News

› Verified 2 days ago

Entity NameAdg Houston Path Pllc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1659617009
PECOS PAC ID: 6901283621
Enrollment ID: O20220519000655

News Archive

LifeVest wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest

The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.

Researchers develop brown fat detection method to combat obesity

When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at The University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.

Diflunisal drug reduces neurological decline in patients with familial transthyretin amyloidosis

A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.

Feeling depressed and fatigued does not increase a person's risk for cancer

...according to a new study. Severely exhausted people, however, do engage in behavior that is associated with a higher cancer risk.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Janice May Wilson is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Janice May Wilson, MD
301 University Blvd,
Galveston, TX 77555-0783

Ph: (409) 772-1911
Janice May Wilson, MD
301 University Blvd, University Of Texas Medical Branch-dermatology,
Galveston, TX 77555-0783

Ph: (409) 772-1911

News Archive

LifeVest wearable cardioverter defibrillator approved for children at risk for sudden cardiac arrest

The U.S. Food and Drug Administration today approved a new indication for the LifeVest wearable cardioverter defibrillator. The LifeVest is approved for certain children who are at risk for sudden cardiac arrest, but are not candidates for an implantable defibrillator due to certain medical conditions or lack of parental consent.

Researchers develop brown fat detection method to combat obesity

When it comes to fat, you want the brown type and not so much of the white variety because brown fat burns energy to keep you warm and metabolically active, while white fat stores excess energy around your waist, causing health problems. Researchers at The University of Texas Health Science Center at Houston Medical School are studying brown fat with a goal of fighting obesity.

Diflunisal drug reduces neurological decline in patients with familial transthyretin amyloidosis

A recent study led by researchers from the Amyloidosis Center at Boston University School of Medicine and Boston Medical Center demonstrates that diflunisal, a generic anti-inflammatory drug, successfully reduced neurological decline and preserved the quality of life in patients with familial transthyretin amyloidosis. Diflunisal is an inexpensive and safe medication marketed over the past 40 years for arthritis and pain.

Antibody agents effective at neutralizing European, South African, and United States SARS-CoV-2 variants

Researchers in the United States have demonstrated the effectiveness of three antibody agents at neutralizing recently emerged variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent responsible for the coronavirus disease 2019 (COVID-19) pandemic.

Feeling depressed and fatigued does not increase a person's risk for cancer

...according to a new study. Severely exhausted people, however, do engage in behavior that is associated with a higher cancer risk.

Read more News

› Verified 2 days ago


Dermatology Doctors in Galveston, TX

Frank Winsett, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1005 Harborside Dr 5th Floor, Galveston, TX 77555
Phone: 409-747-3376    Fax: 409-772-4456
Dr. Ramon Larrea Sanchez, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 1501 Broadway St, Galveston, TX 77550
Phone: 409-763-2452    Fax: 409-763-2458
Michael George Wilkerson, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 400 Harborside Dr, Galveston, TX 77555
Phone: 409-772-2222    
Richard F Wagner Jr., MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 400 Harborside Dr, Galveston, TX 77555
Phone: 409-772-2222    
Lindy Ross, MD
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 301 University Blvd, Galveston, TX 77555
Phone: 409-772-1911    
Dr. Erica B Kelly, M.D.
Dermatology
Medicare: Accepting Medicare Assignments
Practice Location: 301 University Blvd, Galveston, TX 77555
Phone: 409-772-2222    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.